Business Context and Reporting Period
This Form 8-K Current Report is filed by Global Medical REIT Inc. (not Chiron Real Estate Inc.) on August 21, 2017, regarding events occurring on August 20, 2017. The filing addresses significant changes in executive leadership and the appointment of a new Chief Executive Officer.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data contained herein is limited to specific compensation arrangements related to the executive transition:
- Separation Compensation: Two months of salary from the Advisor and immediate vesting of 24,000 unvested LTIP units for the departing CEO.
- Consulting Fees: $7,500 per month in cash fees for acquisition and business development services.
- Acquisition Fee: A 1% fee on off-market healthcare facility acquisition opportunities identified and consummated by the former CEO during the consulting term.
Material Changes
The primary material change reported is the departure of David A. Young, who resigned as Chief Executive Officer and Director effective August 16, 2017. Concurrently, the Board appointed Jeffrey Busch, the Company's President and Chairman, as the new Chief Executive Officer.
Outlook, Risks, and Management Commentary
Management Transition: Jeffrey Busch brings extensive experience in real estate investment and development since 1985. He has served as President of the Company's external Advisor, Inter-American Management LLC, since 2013 and as Chairman and President of the Company since August 2015. He also holds leadership roles at American Housing REIT Inc. and the Safe Blood International Foundation.
Continuity: The transition includes a one-year Consulting Agreement with the departing CEO to facilitate business development, renewable for an additional year subject to conditions.
Risks and Contingencies: The filing notes that the descriptions of the Separation and Consulting Agreements are not complete and are qualified by reference to the full agreements filed as Exhibits 10.1 and 10.2.
Investor Verification Checklist
- Verify the full terms of the Separation Agreement (Exhibit 10.1) and Consulting Agreement (Exhibit 10.2) to understand all conditions for the vesting of LTIP units and the 1% acquisition fee.
- Confirm the effective dates of the resignation (August 16, 2017) and the new CEO appointment (August 20, 2017).
- Review the press release (Exhibit 99.1) for additional context on the strategic rationale for the leadership change.
- Note that the registrant is an emerging growth company.